Login / Signup

An overview of CAR T-cell clinical trial activity to 2021.

Antonella AdamiJohn Maher
Published in: Immunotherapy advances (2021)
Immunotherapy of cancer using chimeric antigen receptor-engineered T-cells has transformed the management of selected haematological malignancies, triggering intense clinical trial activity in this arena. This article summarises trial activity that has been published to date across the spectrum of haematological and solid tumour types.
Keyphrases
  • clinical trial
  • phase ii
  • study protocol
  • phase iii
  • squamous cell carcinoma
  • stem cells
  • systematic review
  • cell therapy
  • young adults